By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS




Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





Company News
IriSys, Inc. Contract With NCI For Manufacturing Clinical Trial Materials Is Doubled In Value 4/20/2017 8:03:47 AM
After Much Anticipation, Cellectar Biosciences  (CLRB) Initiates NCI-Supported Phase II Trial Of CLR 131 In Multiple Myeloma And Other Blood Cancers 3/30/2017 8:12:16 AM
Kite Pharma (KITE) Highlights Publication From NCI Demonstrating Durable Complete Remissions In Patients With Relapsed/Refractory Non-Hodgkin Lymphoma Following Low Dose Conditioning Chemotherapy And Anti-CD19 CAR T-Cell Therapy 3/15/2017 8:09:36 AM
TRACON Pharma (TCON) Announces Top-Line Results From NCI-Sponsored Phase 2 Trial Of TRC105 In Recurrent Glioblastoma 2/10/2017 8:49:11 AM
Kinetic River Corp. Delivers Potomac Modular Flow Cytometer To The NCI 2/7/2017 10:42:29 AM
Personal Genome Diagnostics Awarded NCI Contract To Develop Novel Diagnostic For Immuno-Oncology Drugs 2/1/2017 9:14:03 AM
Agenus (AGEN) Release: Company Announces Collaboration With The NCI To Evaluate The Combination Of Pembrolizumab (Keytruda, Merck & Co. (MRK)) With Prophage (Agenus Inc.) Autologous Vaccine 1/17/2017 10:02:30 AM
Xcovery Release: Company Joins NCI Formulary To Help Expedite Cancer Clinical Trials 1/17/2017 8:03:56 AM
ZIOPHARM Oncology (ZIOP) Release: Biopharma And Intrexon (XON) Announce Cooperative Research And Development Agreement With The NCI Utilizing Sleeping Beauty System To Generate T Cells Targeting Neoantigens 1/10/2017 10:42:37 AM
Threshold Pharma (THLD) And NCI To Collaborate On Drug Candidate TH-3424 12/19/2016 1:09:55 PM
12345678910...
//-->